BESTSELLER99.67%
Images are representative. Products are lyophilised research peptides in sterile vials. Batch certificates are linked when a published summary exists for the current lot — original lab PDFs are available on request where applicable.
Metabolic research
Retatrutide (LY3437943)
Triple GLP-1/GIP/Glucagon agonist for metabolic and obesity research.
Research Overview
Retatrutide (LY3437943) is a first-in-class triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Preclinical and early clinical research has demonstrated significant effects on body weight, glucose metabolism, and lipid regulation. Each vial is lyophilised under nitrogen, HPLC-verified at ≥99.2% purity, and its batch Certificate of Analysis is viewable online.
Select size
Select Quantity
Custom Qty
1
COD
Cash on Delivery
COA
Batch summary online
FREE
Ship ≥ ₹5,000
1–2d
Insulated dispatch
24h
Dispatch
2K+
Orders
99.2%
Purity
5
mg/ml
0.05
ml / aliquot
40
aliquots / vial
Laboratory volume arithmetic only — not dosing, administration, or clinical guidance. Convert mass ÷ concentration yourself for your written lab protocol.
Store lyophilised vials refrigerated (2–8°C), protected from light. Once reconstituted, keep refrigerated and use within the period appropriate to the compound. Shipped in insulated, temperature-controlled packaging.
This product is strictly for laboratory and analytical purposes. Not for human or veterinary use. By ordering, you confirm you are a qualified researcher operating in compliance with applicable regulations.
Regulatory & Research Context
- Intended use
- In-vitro laboratory research only
- Regulatory status
- Not approved as a medicine — not for human or veterinary use
Published research referenced on this site
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — New England Journal of Medicine, 2021
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — New England Journal of Medicine, 2022
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial — New England Journal of Medicine, 2023
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance — Cell Metabolism, 2015
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — New England Journal of Medicine, 2025
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) — New England Journal of Medicine, 2023
- Lilly’s triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial — Eli Lilly and Company — TRIUMPH-1 topline, 2026
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial — Nature Medicine, 2024
Common Questions
Buy Retatrutide in India
| Size | Price (₹) | ₹ per mg | Availability |
|---|---|---|---|
| 5mg | 3,499 | 700 | Out of stock |
| 10mg | 4,999 | 500 | In stock |
| 30mg | 11,999 | 400 | In stock |
Where can I buy Retatrutide in India?
Retatrutide is supplied India-wide by Vitality Peptides for laboratory research use. Every batch is tested by an independent analytical laboratory and its Certificate of Analysis is published on this site before the vial ships, so the exact lot you receive can be checked against its own report.
What does Retatrutide cost in India?
Retatrutide is listed in 2 sizes, from ₹4,999 for the 10mg vial to ₹11,999 for the 30mg. Live pricing and stock are shown on this page, and volume pricing applies automatically at checkout where offered.
What purity is Retatrutide tested to?
The batch currently listed tested 99.67% by RP-HPLC at Janoshik Analytical, an independent third-party laboratory. The full certificate — purity, net peptide content per vial and bacterial endotoxin screening — is published at vitalitypeptides.in/coa/r30-3p, including the lab's own verification reference so the report can be checked at source.
View this batch certificate →Is Retatrutide approved for human use in India?
No. Retatrutide is supplied strictly as a research chemical for laboratory use. It is not a medicine, it is not approved for human or veterinary use in India or elsewhere, and it must not be administered to humans or animals. Purchase is limited to qualified researchers and institutions.
How is Retatrutide shipped and stored?
Vials are supplied lyophilised and shipped India-wide. Store the sealed lyophilised vial refrigerated and protected from light, and handle it according to your own laboratory's written protocols for research materials.